These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

578 related items for PubMed ID: 18928184

  • 1. [Left ventricular hypertrophy in patients on hemodialysis: importance of anemia].
    Stojimirović B, Petrović D, Obrenović R.
    Med Pregl; 2007; 60 Suppl 2():155-9. PubMed ID: 18928184
    [Abstract] [Full Text] [Related]

  • 2. [Left ventricular hypertrophy in patient on dialysis].
    Lovcić V, Sebetić D, Klobucić M, Kusec V.
    Acta Med Croatica; 2003; 57(1):61-4. PubMed ID: 12876866
    [Abstract] [Full Text] [Related]

  • 3. [Characteristics of hyperhomocysteinemia in dialysis patients].
    Lovcić V, Kes P, Reiner Z.
    Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
    [Abstract] [Full Text] [Related]

  • 4. Cardiac mortality prevention in uremic patients. Therapeutic strategies with particular attention to complete correction of renal anemia.
    Berweck S, Hennig L, Sternberg C, Dingerkus H, Ludat K, Hampl H.
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S80-5. PubMed ID: 10746811
    [Abstract] [Full Text] [Related]

  • 5. Cardiac troponins and left ventricular hypertrophy in hemodialysis patients.
    Petrović D, Obrenović R, Stojimirović B.
    Clin Lab; 2008 Feb; 54(5-6):145-52. PubMed ID: 18780659
    [Abstract] [Full Text] [Related]

  • 6. The cardiovascular and hemodynamic effects of erythropoietin in chronic renal failure.
    Singh NP, Chandrashekhar, Nair M, Anuradha S, Kohli R, Agarwal SK.
    J Assoc Physicians India; 2000 Mar; 48(3):301-6. PubMed ID: 11229114
    [Abstract] [Full Text] [Related]

  • 7. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H, Baradaran A.
    J Ayub Med Coll Abbottabad; 2004 Mar; 16(2):3-8. PubMed ID: 15455608
    [Abstract] [Full Text] [Related]

  • 8. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
    Wang AY, Wang M, Woo J, Lam CW, Lui SF, Li PK, Sanderson JE.
    J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients.
    Sit D, Kadiroglu AK, Yilmaz ME, Kara IH, Isikoglu B.
    Ren Fail; 2005 Aug; 27(4):403-7. PubMed ID: 16060127
    [Abstract] [Full Text] [Related]

  • 12. [Correlation of C-reactive protein with echocardiographic parameters of hypertrophic and ischemic heart disease in patients on regular hemodialyses].
    Petrović D, Obrenović R, Poskurica M, Stojimirović B.
    Med Pregl; 2007 Aug; 60 Suppl 2():160-4. PubMed ID: 18928185
    [Abstract] [Full Text] [Related]

  • 13. Arterial blood pressure and left ventricular hypertrophy in haemodialysis patients.
    de Lima JJ, Abensur H, Krieger EM, Pileggi F.
    J Hypertens; 1996 Aug; 14(8):1019-24. PubMed ID: 8884558
    [Abstract] [Full Text] [Related]

  • 14. The long-term behavior and predictors of left ventricular hypertrophy in hemodialysis patients.
    Kutlay S, Dincer I, Sengül S, Nergizoglu G, Duman N, Ertürk S.
    Am J Kidney Dis; 2006 Mar; 47(3):485-92. PubMed ID: 16490628
    [Abstract] [Full Text] [Related]

  • 15. Prevalence and risk factors of myocardial remodeling in hemodialysis patients.
    Dimitrijevic Z, Cvetkovic T, Stojanovic M, Paunovic K, Djordjevic V.
    Ren Fail; 2009 Mar; 31(8):662-7. PubMed ID: 19817519
    [Abstract] [Full Text] [Related]

  • 16. The relationship of visfatin levels to inflammatory cytokines and left ventricular hypertrophy in hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Erten Y, Ebinç FA, Ebinç H, Paşaoğlu H, Demirtaş C, Taçoy G, Koç E, Derici U, Reis KA, Bali M, Arinsoy T, Sindel S.
    Ren Fail; 2008 Mar; 30(6):617-23. PubMed ID: 18661412
    [Abstract] [Full Text] [Related]

  • 17. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.
    Unver S, Kavlak E, Gümüsel HK, Celikbilek F, Esertas K, Muftuoglu T, Kirilmaz A.
    Ren Fail; 2015 Jul; 37(6):951-6. PubMed ID: 26030798
    [Abstract] [Full Text] [Related]

  • 18. Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin.
    Silberberg J, Racine N, Barre P, Sniderman AD.
    Can J Cardiol; 1990 Jul; 6(1):1-4. PubMed ID: 2138048
    [Abstract] [Full Text] [Related]

  • 19. The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey.
    Paoletti E, Specchia C, Di Maio G, Bellino D, Damasio B, Cassottana P, Cannella G.
    Nephrol Dial Transplant; 2004 Jul; 19(7):1829-34. PubMed ID: 15128888
    [Abstract] [Full Text] [Related]

  • 20. Epoetin alfa's effect on left ventricular hypertrophy and subsequent mortality.
    Jones M, Schenkel B, Just J.
    Int J Cardiol; 2005 Apr 20; 100(2):253-65. PubMed ID: 15823633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.